These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 28339387)

  • 21. Applying Quality by Design Concepts to Pharmacy Compounding.
    Timko RJ
    Int J Pharm Compd; 2015; 19(6):453-63. PubMed ID: 26891559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meningitis outbreak shines light on compounding pharmacies.
    Shaughnessy AF
    BMJ; 2012 Nov; 345():e7432. PubMed ID: 23129491
    [No Abstract]   [Full Text] [Related]  

  • 23. [PICS: pharmaceutical inspection cooperation scheme].
    Morénas J
    Ann Pharm Fr; 2009 Jan; 67(1):16-9. PubMed ID: 19152846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The art, science, and practice of pharmacy compounding.
    McDonough RP; Allen LV; Wettergreen S
    J Am Pharm Assoc (2003); 2013; 53(1):8-12. PubMed ID: 23636149
    [No Abstract]   [Full Text] [Related]  

  • 25. Does your pharmacy have a compounding isolator?
    LaBella CJ
    Am J Health Syst Pharm; 2007 Apr; 64(8):855-8. PubMed ID: 17420203
    [No Abstract]   [Full Text] [Related]  

  • 26. End-preparation assessments and tests for compounded sterile preparations.
    McElhiney LF
    Int J Pharm Compd; 2013; 17(4):307-11. PubMed ID: 24261146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential risks of pharmacy compounding.
    Gudeman J; Jozwiakowski M; Chollet J; Randell M
    Drugs R D; 2013 Mar; 13(1):1-8. PubMed ID: 23526368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How gaps in regulation of compounding pharmacy set the stage for a multistate fungal meningitis outbreak.
    Teshome BF; Reveles KR; Lee GC; Ryan L; Frei CR
    J Am Pharm Assoc (2003); 2014; 54(4):441-5. PubMed ID: 25063265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thoughts on the improvement of the quality of the drugs prepared in the pharmacy].
    Hädicke M
    Pharm Prax; 1966 Apr; 4():103-4. PubMed ID: 6001079
    [No Abstract]   [Full Text] [Related]  

  • 30. The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives.
    Blankenship C
    Int J Pharm Compd; 2018; 22(1):26-28. PubMed ID: 29385383
    [No Abstract]   [Full Text] [Related]  

  • 31. GMPs vs GCPs: manufacturing and compounding definitions.
    Allen LV
    Int J Pharm Compd; 2013; 17(5):356. PubMed ID: 24459778
    [No Abstract]   [Full Text] [Related]  

  • 32. A growing codependency: compounding pharmacy and safety.
    Prince B; Lundevall J
    Int J Pharm Compd; 2013; 17(6):485-9. PubMed ID: 24579299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E-prescribing errors identified in a compounding pharmacy: a quality-improvement project.
    Reed-Kane D; Kittell K; Adkins J; Flocks S; Nguyen T
    Int J Pharm Compd; 2014; 18(1):83-6. PubMed ID: 24881345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 1: Physical and Chemical Testing.
    Allen LV
    Int J Pharm Compd; 2019; 23(3):211-216. PubMed ID: 31085790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbial Identification in Pharmaceutical Compounding.
    Hyde T; Anstead J; Schade L; Zellner J
    Int J Pharm Compd; 2016; 20(1):13-8. PubMed ID: 27125052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality control analytical methods: strategies to ensure a robust quality-control microbiology program.
    Griffiths T; Connors A
    Int J Pharm Compd; 2013; 17(2):130-4. PubMed ID: 23696174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Practice of Compounding, Associated Compounding Regulations, and the Impact on Dermatologists.
    Quertermous J; Desai S; Harper J; Lebwohl M; Torres A; Kircik LH
    J Drugs Dermatol; 2018 Jul; 17(7):s17-s22. PubMed ID: 30005109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving and enforcing compounding pharmacy practices to protect patients.
    Pegues DA
    Clin Infect Dis; 2006 Oct; 43(7):838-40. PubMed ID: 16941363
    [No Abstract]   [Full Text] [Related]  

  • 39. Causes and root causes of a multistate fungal meningitis outbreak.
    Lipowski EE; Smith WT; Navarro RP
    J Am Pharm Assoc (2003); 2015; 55(2):118. PubMed ID: 25616150
    [No Abstract]   [Full Text] [Related]  

  • 40. Description of outbreaks of health-care-associated infections related to compounding pharmacies, 2000-12.
    Staes C; Jacobs J; Mayer J; Allen J
    Am J Health Syst Pharm; 2013 Aug; 70(15):1301-12. PubMed ID: 23867487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.